NCT04334057Completed
Post-Marketing Surveillance (Use-results Surveillance) With Esperoct®
Post-Marketing Surveillance (Use-results Surveillance) With Esperoct®. A Multi-centre, Prospective, Observational, Non-interventional Post-marketing Study to Investigate the Long-term Safety and Effectiveness of Esperoct® in Haemophilia A Patients Under Routine Clinical Practice Conditions in Japan
Source: ClinicalTrials.gov · Last updated 15 Jun 2026
Brief summary (registry, in English)
The purpose of this study is to assess the safety and effectiveness of Esperoct® for long-term routine use in patients with Haemophilia A. Participants will get Esperoct® as prescribed by their doctor. The study will last for about 2 years for each participant.
- Status (registry)
- Completed
- Study type
- Observational
- Enrollment
- 23 (actual)
- First submitted
- 2 Apr 2020
- Start date
- 31 Mar 2021
- Primary completion date
- 30 Nov 2023
- Lead sponsor
- Novo Nordisk A/S
- Diseases
- Haemophilia
- NCT number
- NCT04334057
What you commit to
- Study type: Observational
- Participants enrolled: 23
- From 31 Mar 2021 to the primary completion date, 30 Nov 2023
- 20 sites in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Previous participation in this study. Participation is defined as having given informed consent in this study.
Other illness
- Known or suspected hypersensitivity to study product or related products.
Other
- Mental incapacity, unwillingness or language barriers precluding adequate understanding or cooperation.
Who the study is looking for
- Signed consent obtained before any study-related activities (study-related activities are any procedure related to recording of data according to the protocol).
- The decision to initiate treatment with commercially available Esperoct® has been made by the patient/Legally Acceptable Representative (LAR) and the treating physician before and independently from the decision to include the patient in this study.
- Diagnosis of haemophilia A in males or females, no age limitation.
- New patients who have not previously been exposed to Esperoct®.
Sex: All
Sites (20)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Kurume University Hospital, Pediatrics Coordinator of this site? Confirm its status | Fukuoka | Japan | Unknown status |
| Gifu University Hospital_The Third Dept. of Internal Medicine Coordinator of this site? Confirm its status | Gifu | Japan | Unknown status |
| Gifu University Hospital Coordinator of this site? Confirm its status | Gifu | Japan | Unknown status |
| Saitama Medical University Hospital, Pediatrics Coordinator of this site? Confirm its status | Iruma-gun, Saitama | Japan | Unknown status |
| University Hospital Kyoto Prefectual University of Medicine Coordinator of this site? Confirm its status | Kamigyo-ku, Kyoto | Japan | Unknown status |
| St. Marianna University School of Medicine Hospital_Pediatrics Coordinator of this site? Confirm its status | Kanagawa | Japan | Unknown status |
| St. Marianna University School of Medicine Hospital Coordinator of this site? Confirm its status | Kanagawa | Japan | Unknown status |
| Nara Medical University Hospital_Pediatrics Coordinator of this site? Confirm its status | Nara | Japan | Unknown status |
| Nanbu Medical Center & Children's Medical Center_Pediatric Hematology Coordinator of this site? Confirm its status | Okinawa | Japan | Unknown status |
| Shibuya Children's Clinic, Department of Pediatric Coordinator of this site? Confirm its status | Saitama | Japan | Unknown status |
| Lake Children Clinic Coordinator of this site? Confirm its status | Shiga | Japan | Unknown status |
| Shizuoka Children's Hospital, Hematology-Oncology Coordinator of this site? Confirm its status | Shizuoka | Japan | Unknown status |
| Shizuoka Children's Hospital Coordinator of this site? Confirm its status | Shizuoka | Japan | Unknown status |
| Ogikubo Hospital_Blood Coagulation Coordinator of this site? Confirm its status | Tokyo | Japan | Unknown status |
| Nippon Medical School Hospital_Haematology Coordinator of this site? Confirm its status | Tokyo | Japan | Unknown status |
| Tokyo Medical Univ. Hospital Coordinator of this site? Confirm its status | Tokyo | Japan | Unknown status |
| Tokyo Medical Univ. Hospital_Laboratory Medicine Coordinator of this site? Confirm its status | Tokyo | Japan | Unknown status |
| Nihonkai Sogo Hospital_Internal Medicine Coordinator of this site? Confirm its status | Yamagata | Japan | Unknown status |
| Nihonkai Sogo Hospital Coordinator of this site? Confirm its status | Yamagata | Japan | Unknown status |
| St. Marianna Univ., Yokohama City Seibu HP, Pediatrics Dept, Coordinator of this site? Confirm its status | Yokohama-shi, Kanagawa | Japan | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.